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Abstract
Background: African trypanosomiasis affects both humans and livestock in sub-Saharan countries including
Ethiopia. Due to limitations to current chemotherapy, there is an urgent need for the development of new,
safe, cheap and effective drugs. In the present study, the leaf of Dovyalis abyssinica was tested for its in vivo
antitrypanosomal activity against Trypanosoma congolense field isolate on mice.
Methods: The leaf of D. abyssinica was macerated using dichloromethane and methanol. The extracts at doses of
250, 200, 150 and 100 mg/kg body weight were administered intraperitonealy daily for 7 days to mice infected
with T. congolense. Following administration, parasitemia, packed cell volume, rectal temperature, body weight and
survival time were monitored.
Results: Administration of dichloromethane and methanol extracts at 250 and 200 mg/kg reduced (p < 0.05)
parasitemia and rectal temperature, and improved (p < 0.05) PCV, mean body weight, and mean survival time
compared to dimethylsulfoxide treatment.
Conclusion: Crude dichloromethane and methanol leaf extracts of D. abyssinica displayed anti-trypanosomal
activity that may serve as lead for the development of effective alternative antitrypanosomal drugs.
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Background
The genus Trypanosoma causes potentially fatal human
and animal trypanosomiasis in Africa and South America.
The protozoal species Trypanosoma brucei rhodesience
and T.b. gambience cause a fly-born severe Human
African Trypanosomiasis (HAT) or sleeping sickness in
Africa probably since many centuries ago [1, 2].
T. congolense, T. vivax and T.b. brucei cause African
Animal trypanosomiasis (AAT) [3]. The occurrence of
animal trypanosomiasis coincides with the distribution
of tsetse fly vectors which includes the regions between
latitudes 14°N and 29°S [4]. The disease is the major
constraint to livestock productivity. It causes a great eco-
nomic loss in the livestock industry with an estimated 3
million cattle death annually. Estimated direct produc-
tion losses in cattle to African farmers are between 1
and 4 billion US dollars per year [5]. In Ethiopia, it has
been described as a major impediment to the livestock
development and agricultural production [6].
Despite the development of vector control tools and
vaccine candidates over the years, the control of tryp-
anosomiasis has continued to rely heavily on the use of
trypanocidal drugs. However, effectiveness of current
treatment is limited by many factors [7–9], necessitating
the search for new improved drugs. Moreover, because
those in the lower socioeconomic class are dispropor-
tionately affected by the disease, there is a great need for
the development of not only less toxic and more effect-
ive drugs but also affordable agents [10, 11].
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Dovyalis abyssinica (A. Rich) Warb. (Salicaceae) is a
spiny evergreen shrub or tree containing of dovyalicin-
type alkaloids, dovyalicin E and dovyalicin F, Dovyalicin
A [12]. The plant displayed antibacterial and antifungal
activity [13]. Recently, Nibret and Wink [14] reported on
the in vitro anti-trypanosomal activity of the plant
against T. b. brucei. Hence, this work was conducted to
evaluate the in vivo anti-trypanosomal effects of crude
dichloromethane and methanol leaf extracts of D. abyssi-
nica on the most pathogenic East AAT, T. congolense.
Methods
Chemicals
Analytical grade solvents and reagents used in this work
were; dichloromethane (DCM) (BDH laboratory supplies,
England), methanol (MOH) (Sigma Aldrich, Germany),
diethyl ether (Blulux Laboratories, India), diminazene
aceturate (DA) (BerenilÒ, Hoechst, Germany), dimethyl-
sulphoxide (DMSO) (BDH laboratory supplies, England).
Preparation of plant extracts
The fresh leaves of D. abyssinica were collected in Feb-
ruary, 2013, from Debrezeit, about 47.9 km Southeast of
Addis Ababa, Ethiopia. Identification and authentication
of the plant was done at the National Herbarium,
Department of Biology, Addis Ababa University, Addis
Ababa, where a voucher specimen was deposited (collec-
tion number BT001/13). The fresh plant material was
rapidly washed under running tap water, shade air dried
at room temperature until brittle, and grounded to
coarse powder using laboratory pestle and mortar. The
powdered plant material was extracted using two sol-
vents; DCM and MOH as used by [12, 14]. To obtain
DCM extracts, 200 g were macerated in 2000 ml of
DCM in conical flask for three days. Similarly, to obtain
MOH extract 200 g of powder were macerated in
2000 ml of MOH. The residue left after maceration was
successively extracted twice with the same medium
separately. For each of the two solvents extracts were
collected in separate flasks and left undisturbed before
being filtered through a sterile filter paper (wattman
No. 1) into a clean conical flask. The filtrate was dried
by evaporating the solvents using oven. The dried ex-
tracts were weighed and placed in refrigerator at 4 °C
until needed.
Experimental animals
Swiss albino mice (20–35 g) of both sexes aged 10–12
weeks were obtained from the breeding colony of
school of pharmacy, Addis Ababa University. The mice
were housed in polypropylene cages and maintained
under room temperature and 12 h light and dark cycle.
The animals were left under controlled conditions
at least for one week to acclimatize them before
conducting any experimental procedure. Usage of mice
in experiment was in accordance with Institute for
Laboratory Animals’ Resources (ILAR) Guideline [15],
and was approved by research and ethics committee of
the School of Pharmacy, Addis Ababa University.
Isolation of T. congolense
T. congolense field isolate was collected from Illibabur
Zone, Dabu woreda, Sebategna district, about 523 km
Southwest of Addis Ababa. Cattle were screened for the
presence of T. congolense using the buffy coat technique
or Murray method [16]. Presence of T. congolense was
identified based on motility and further confirmed by
National Tsetse and Trypanosomiasis Control Centre
(NTTCC) in Bedelle following thin blood smear prepar-
ation. They were fixed by MOH and stained with
Giemsa stain and read using an oil immersion objective
(40–50× for scanning, 100× for identification of trypano-
somes). The morphology of the trypanosome in the
stained field was compared with that of reference species
[17]. Blood was then drawn from the jugular vein of the
positive cattle using heparinized vacutainer tube and
injected (0.5 ml in two divided doses) intraperitonealy to
apparently healthy mice and rats and transported to
Aklilu Lemma Institute of Pathobiology, Addis Ababa
University. After establishment of infection, the organisms
were maintained by serial passages in mice until required
as described by [18].
Acute toxicity study
Acute toxicity test was carried out according to the
Organization for Economic Co-operation and Develop-
ment (OECD) guidelines for Testing of Chemicals num-
ber 420 [19] and Lorke’s method [20] on female mice
aged 10–12 weeks weighing 20–35 g. The test was initi-
ated with a sighting study treating one female mouse for
each of the two extracts in a stepwise procedure with
the fixed doses 300 and 2000 mg/kg. Oral 300 mg/kg of
both extracts did not cause any signs of toxicity in mice
throughout the monitoring period. However, a single
2000 mg/kg oral dose of each extracts produced death of
a mouse. Median lethal dose was estimated using twenty
adult female mice grouped in to eight groups performed
in two phases [20]. At 10, 100, and 1000 mg/kg IP
doses there were no noticeable signs of toxicity. How-
ever administration of 1600 mg/kg dichloromethane and
methanol extracts caused the death of a mouse. The






(where a = least dose that killed a mouse, while b = high-
est dose that did not kill any mice) was 1,265 mg/kg
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body weight. Based on this result four doses (100, 150,
200 and 250 mg/kg) were selected for the in vivo
studies.
Preliminary phytochemical screening
Standard screening tests of the crude extracts were car-
ried out for secondary metabolites according to the
methods discussed in the literature [21].
Test for alkaloids
To 1 ml of test solution, few drops of Dragendorff ’s and
Mayer’s reagent were added and formation of precipitate
indicates a positive result.
Test for saponins
About 0.5 g of the extract was dissolved in 10 ml of dis-
tilled water in a test tube. The test tube was stoppered
and shaken vigorously for 30 s and allowed to stand in a
vertical position and observed over 30 min. Formation
of a “honey comb” froth over the surface of liquid and
persistence after 30 min indicates presence of saponins.
Test for tannins
To 2 ml of water diluted sample 3 drops of 10 % ferric
chloride were added. The formation of bluish-black
color denotes the presence of tannins.
Test for sterols and terpenes
To 1 ml of test solution, few drops of concentrated
sulphuric acid in a slant position was added and left
standing for an hour. The formation of a brown ring at
interphase indicates the presence of sterols and terpenes.
Test for flavonoids
To 1 ml of the test solution, 3mls of 10 % sodium hy-
droxide was added followed by 3mls of 10 % HCl. The
formation of a yellow color on addition of sodium hy-
droxide, which disappeared on addition of the HCl, indi-
cates the presence of flavonoids.
Test for steroids
The test for steroids was done by the Liebermann acid
test. A portion of the extract was treated with drops of
acetic anhydride. Concentrated H2SO4 was carefully
added to the side of the test tube. The presence of a
brown ring at the boundary of the mixture was taken as
positive result.
Test for phenolic compounds
To 2 ml of filtered solution 1 ml of 1 % ferric chloride
(FeCl3 and 1 ml of potassium ferrocyanate (K4Fe(CN)6)
were added. Formation of bluish green color indicated
the presence of phenolic compounds.
Parasite inoculation and extract administration
A total of fifty (50) apparently healthy mice of both
sexes were randomly grouped into 10 groups (DCM-
250 mg/kg, DCM-200 mg/kg, DCM-150 mg/kg, DCM-
100 mg/kg, MOH-250 mg/kg, MOH-200 mg/kg, MOH-
150 mg/kg, MOH-100 mg/kg, DA, and DMSO) of five
mice of both sexes each. Infected blood containing 2 ×
106 trypanosomes/ml was collected from donor mice by
cardiac puncture under diethyl ether anesthesia and di-
luted with phosphate buffered saline (PBS) to contain
103 trypanosomes/ml. All groups of mice were then in-
fected intraperitoneally (IP) with 0.2 ml of infected
blood/PBS [18]. The animals were left to develop para-
sitemia and 12 days post parasite challenge [22], when
the parasitemia level reached 1.58 × 107 trypanosomes/
ml, Groups DCM-250 mg/kg, DCM-200 mg/kg, DCM-
150 mg/kg, and DCM-100 mg/kg were administered
with doses at 250, 200, 150 and 100 mg/kg body weight
(BW), respectively, of the DCM extract, while groups
MOH-250 mg/kg, MOH-200 mg/kg, MOH-150 mg/kg,
and MOH-100 mg/kg received respective MOH extracts
of 250, 200, 150, 100 mg/kg BW IP once daily every
morning for 7 days. The extracts and diminazene acetu-
rate were separately dissolved and reconstituted in 10 %
DMSO. Whereas infected mice in group DA received
28 mg/kg of diminazene aceturate [23]. The last group
was administered with DMSO to serve as a negative
control.
Determination of parasitemia
Parasitemia was monitored by examination of blood
drawn from the tail of mice microscopically at ×400
magnification using the “Rapid Matching” method of
Herbert and Lumsden [24]. Briefly, the method involves
microscopic counting of parasites per field in pure
blood. Logarithm values of these counts were obtained
by matching with the table of Herbert and Lumsden
[24]. Monitoring of parasitemia (average taken from two
independent laboratory technicians’ data) was performed
every other day until the 14th day post-treatment initi-
ation. For the assessment of anti-trypanosomal effect of
the extracts, the level of parasitemia in the treated ani-
mals was compared to that of the control animals [25].
Determination of packed cell volume
Packed Cell Volume (PCV) was determined using micro-
haematocrit centrifuge and microhaematocrit tube reader.
Microhaematocrit centrifuge, fitted with head capable for
carrying 24 capillary tubes and a revolution of 11,
000 rpm for five minutes was used. The heparinized capil-
lary tube was ¾ filled with blood samples obtained from
the tail vein of the mice. The end of the tube was sealed
and excess cleared off using cotton wool. The filled tubes
were placed in a slot in the centrifuge head with sealed
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end outward. A special scale, the microhaematocrit reader
was used to obtain the PCV percentage and the reading
recorded [26]. PCV was monitored on day of parasite
inoculation, treatment initiation, and 7th and 14th post-
treatment initiation.
Determination of rectal temperature
Rectal temperature was measured by digital rectal
thermometer (Mettler Toledo, Switzerland) per rectum
on the day of parasite inoculation, day of treatment
commencement and every other day thereafter for
2 weeks [27].
Determination of body weight
The BW of each mouse in all groups was recorded follow-
ing the period of fasting on the day of parasite challenge,
day of treatment initiation, and every other day for 2 weeks
by a sensitive digital weighing balance (Mettler Toledo,
Switzerland) [27].
Determination of mean survival time
Mortality was monitored daily and the number of days
from the time of inoculation of the parasite up to death
was recorded for each mouse in the treatment and
control groups throughout the follow up period for
6 weeks [28].
Statistical analysis
All data generated during the course of the research were
expressed as mean ± standard deviation (SD) and analyzed
statistically by one way ANOVA followed by Tukey’s mul-
tiple comparison tests to determine statistical significance.
The level of significance for the differences between
means within group was computed by student’s t test.
Data analysis was performed using Statistical Package for
Social Science (SPSS) version 16. P values less than 0.05
were considered statistically significant.
Results
Phytochemical constituents of D. abyssinica
Phytochemical screening tests performed on the leaf
extracts of D. abyssinica revealed the presence of alka-
loids, sapponins, phenolic compounds, flavonoids, and
steroids (Table 1).
Effect of extracts on parasitemia
Treatment with the extracts resulted in reduction in the
level of parasitemia generally between days 14 and 22
compared to the negative control, in which there was a
progressive rise in parasitemia throughout the 2 weeks
monitoring period. Higher doses of DCM extract (250 and
200 mg/kg) significantly (p < 0.05) reduced the parasite
load between D14 and D20, compared to the lowest doses
(DCM-150 mg/kg and DCM-100 mg/kg) and the DMSO-
treated control. Especially, DCM-250 mg/kg was shown to
reduce parasitemia level to approximately 12 (101.08) try-
panosomes/ml at D20, though failed to totally clear the
trypanosomes from the blood, and displayed comparable
activity to diminazene aceturate (p > 0.05) from D18 to
D20. Compared to DCM-250 mg/kg, DCM-200 mg/kg
displayed higher activity which failed to reach statistical
significance (p > 0.05), except at D16 (p < 0.05). Even
though the activity was lower than (p < 0.05) the two
higher doses, DCM-150 mg/kg significantly (p < 0.05) con-
trolled the progression of parasitemia compared to the
lowest dose (100 mg/kg) and infected DMSO-treated
groups. Still DCM-100 mg/kg-treated was statistically su-
perior (p < 0.05) to DMSO-treated group in reducing
parasitemia (Table 2).
On the other hand, only MOH-250 mg/kg and
MOH-200 mg/kg were shown to significantly reduce
parasitemia level from D14 to D20 compared to the
lowest two doses (150 and 100 mg/kg) and DMSO-
treated groups. Within this period, compared to MOH-
200 mg/kg the parasitemia reduction was shown to be
higher in the MOH-250 mg/kg -treated group, though
failed to reach statistical significance (p > 0.05) except
at D20 (p < 0.05). MOH-250 mg/kg displayed statisti-
cally similar (p > 0.05) parasitemia reduction to dimina-
zene aceturate at D18 through D22. Unfortunately, all
the MOH extracts were not able to totally clear T. con-
golense from the blood of infected mice. Even, the low-
est two doses (MOH-150 mg/kg and MOH-100 mg/kg)
was statistically indifferent from DMSO (p > 0.05)
(Table 3). However, treatment with 28 mg/kg dimina-
zene aceturate temporarily cleared T. congolense from
the blood within 2 days post-treatment initiation which
reached statistical significance (p < 0.05) compared to
all extracts-, except DCM-250 mg/kg and MOH-
250 mg/kg, and DMSO treated groups. Relapse in this
group was recorded in all mice after D24. The com-
parative analysis revealed that DCM extract appeared
to be superior to the MOH extract in reducing parasite
burden. Mice treated with DCM-250 mg/kg had con-
tinually reduced parasitemia level from D14 to D20
Table 1 Phytochemicals of crude DCM and MOH leaf extracts
of D. abyssinica




Phenolic compounds + −
Flavonoids + +
Sterols and terpenes − −
Steroids − +
Key: + Present; − Absent
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which was further kept on average at lowest level up to
the end of monitoring period. This was statistically signifi-
cant (p < 0.05) compared to MOH-250 mg/kg (on D16)
and MOH-200 mg/kg (on D16, D18, D20, and D22).
MOH-250 mg/kg was significantly superior (p < 0.05) in
reducing parasitemia compared to DCM-150 mg/kg (D16,
D20 and D22) and DCM-100 mg/kg (D16-D22). Though
high parasitemia reduction was observed with DCM
extract compared to similar dose of MOH extract, the dif-
ference failed to reach statistical significance (p > 0.05),
except on D16.
Effect of extracts on packed cell volume
Figure 1 shows that T. congolense caused a significant
PCV reduction (p < 0.05) in infected mice as the average
value was found to drop from 49.04 ± 0.30 to 50.50 ±
0.50 on the day of parasite inoculation to 44.64 ± 0.42 to
48.08 ± 0.14 on the day of treatment initiation. Seven
days post-treatment initiation the PCV level significantly
(p < 0.01) improved in those groups which received
DCM-250 mg/kg compared to those treated with the
DCM-150 mg/kg and DCM-100 mg/kg and the nega-
tive control. Similarly, compared to the negative con-
trol, DCM-200 mg/kg-treated mice had improved PCV
(p < 0.01). However, mice treated with DCM-150 mg/kg
and DCM-100 mg/kg doses had a consistently reduced
PCV values, though statistically indifferent (p > 0.05)
from those treated with DCM-200 mg/kg.
The PCV improvement brought by DCM-250 mg/kg
and DCM-200 mg/kg were statistically similar (p > 0.05)
to each other. On D22, PCV was further improved sig-
nificanty (p < 0.01) in mice treated with DCM-250 mg/
kg and DCM-200 mg/kg compared to those treated
with DCM-150 mg/kg and DCM-100 mg/kg and the
negative control. Likewise, 7 days post-treatent initi-
ation MOH-250 mg/kg and MOH-200 mg/kg treated
animals showed improved PCV level (p < 0.01) compared
to those treated with MOH-150 mg/kg, MOH-100 mg/kg,
and negative control whose PCV declined continuously.
This effect of MOH-250 mg/kg and MOH-200 mg/kg
was significantly high (p < 0.01) compared to MOH-
150 mg/kg, MOH-100 mg/kg, and negative control dur-
ing the end of the monitoring day (D26), though higher
PCV increment (p < 0.05) was obtained from MOH-
250 mg/kg than MOH-200 mg/kg. Comparative ana-
lysis revealed that comparable doses of DCM extracts
were superior to MOH extracts on D19 and vice versa
on D26, but the difference failed to reach statistical sig-
nificance (p > 0.05). Despite the significant enhance-
ment in mean PCV level at these highest doses, it was
Table 2 In vivo anti-trypanosomal activity of dichloromethane crude leaf extract of D. abyssinica on parasitemia of T. congolense
infected mice
Rx D(mg/kg) Parasitemia level (log number/ml)
D12 D14 D16 D18 D20 D22 D24 D26
DCM 250 6.96 ± .25 6.66 ± .39bcd 5.70 ± .37a 2.16 ± 3.04bcd 1.08 ± 2.41bcd 2.16 ± 2.96bcd 3.24 ± 2.96a 4.32 ± 2.41
200 6.66 ± .58 6.48 ± .54cd 6.12 ± .45cd 4.5 ± 2.52 3.24 ± 2.98cd 3.24 ± 2.98cd 5.52 ± .16 5.88 ± .16
150 6.66 ± .58 6.72 ± .27cd 6.54 ± .33cd 6.12 ± .40 5.88 ± .34 5.70 ± .30 5.94 ± .39 6.06 ± .39
100 6.90 ± .47 7.14 ± .58 7.32 ± .62 7.32 ± .62 7.20 ± .60 7.86 ± .49 8.22 ± .40 8.46 ± .25
DA 28 7.08 ± .54 .00 ± .00 .00 ± .00 .00 ± .00 .00 ± .00 .00 ± .00 1.08 ± 1.0 2.16 ± 1.32
DMSO - 7.08 ± .16 7.26 ± .25 7.48 ± .30 7.74 ± .25 7.74 ± .13 8.04 ± .25 8.04 ± .25 8.46 ± .25
Values are Mean ± SD; p < 0.05; N = 5; acompared to all but diminazene aceturate; bcompared to DCM 150 mg/kg; ccompared to DCM 100 mg/kg; dcompared
to DMSO
Rx Treatment, D Dose, DCM Dichloromethane extract, DA Diminazene aceturate, DMSO Dimethylsulfoxide, D Day, D12 Day of treatment initiation
Table 3 Anti-trypanosomal activity of crude methanol leaf extract of D. abyssinica on parasitemia of mice infected with T. congolense
Rx D(mg/kg) Parasitemia level (log number/ml)
D12 D14 D16 D18 D20 D22 D24 D26
MOH 250 7.08 ± .16 6.84 ± .25bcd 6.24 ± .25bcd 3.30 ± .13bcd 1.08 ± 2.55a 2.16 ± 2.96a 4.38 ± 2.45bcd 5.52 ± .16
200 7.02 ± .16 6.78 ± .16bcd 6.48 ± .16bcd 5.94 ± .13 5.58 ± .16 5.76 ± .25 6.00 ± .21 6.12 ± .34
150 7.02 ± .27 7.20 ± .3.7 7.32 ± .27 7.14 ± .25 7.26 ± .25 7.44 ± .25 7.56 ± .25 7.68 ± .34
100 7.08 ± .16 7.32 ± .16 7.74 ± .25 7.98 ± .34 8.10 ± .37 8.28 ± .34 8.22 ± .27 8.40 ± .21
DA 28 7.08 ± .54 .00 ± .00 .00 ± .00 .00 ± .00 .00 ± .00 .00 ± .00 1.08 ± 1.0 2.16 ± 1.32
DMSO - 7.08 ± .16 7.26 ± .25 7.48 ± .30 7.74 ± .25 7.74 ± .13 8.04 ± .25 8.04 ± .25 8.46 ± .25
Values are mean ± SD; N = 5; p < 0.05; acompared to all but DA; bcompared to 150 mg/kg; ccompared to 100 mg/kg; dcompared to DMSO
MOH Methanol extract, Rx Treatment, D Dose, DA Diminzene aceturate, DMSO Dimethylsulfoxide, D Day, D12 Day of treatment initiation
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significantly lower compared to that brought by dimin-
azene aceturate (p < 0.05) on D19 and D26.
Effect of extracts on rectal temperature
The mean rectal temperature at the day of infection
(36.34 ± 0.25 to 36.96 ± 0.10) was elevated following in-
fection (38.02 ± .24 to 38.64 ± 0.33), which indicated
fever was manifested (p < 0.05) in mice infected with T.
congolense (Fig. 2a and b). Mice treated with DCM-
250 mg/kg and DCM-200 mg/kg produced pronounced
fever reduction (p < 0.05) from D16 until the end of
monitoring period compared to those treated with DCM-
150 mg/kg, DCM-100 mg/kg, and DMSO. Whereas the
reduction in rectal temperature caused by these two doses
was comparable (p > 0.05), DCM-250 mg/kg was superior
to DCM-200 mg/kg on D16-D26. Despite this, the rectal
temperature was shown to slowly rise after D22 (Fig. 2a).
By contrast, MOH-200 mg/kg was unable to significantly
reduce rectal temperature (p > 0.05) compared to DMSO.
Only MOH-250 mg/kg ameliorated temperature eleva-
tion from D16 to the final monitoring day, which
reached statistical significance (p < 0.05) compared to
all doses of MOH and the negative control. However,
rectal temperature started to rise on D22 (Fig. 2b).
Comparative analysis indicated that DCM-250 mg/kg
and DCM-200 mg/kg were superior to respective
MOH-250 mg/kg and MOH-200 mg/kg doses in ameli-
orating rectal temperature elevation, though the differ-
ence failed to reach statistical significance (p > 0.05). In
spite of this none, except DCM-250 mg/kg on D20, of
these doses was comparable (p < 0.01) to 28 mg/kg
diminazene aceturate in preventing rectal temperature
rise associated with the infection.
Effect of extracts on body weight
Before treatment commencement all groups show 7.5–
9.15 % weight loss associated with parasitemia. However,
treatment with the crude extracts prevented this loss in
BW particularly at 250 and 200 mg/kg dose levels of
DCM extract and 250 mg/kg of the MOH extract com-
pared to the negative control. There were no detectable
difference in BW improvement among these doses as
well as between the extracts and the standard (28 mg/
kg) throughout the monitoring period (Fig. 3a and b).
Compared to the negative control, groups treated with
all doses of DCM extract, except 100 mg/kg, signifi-
cantly (p < 0.05) improved BW of infected mice through-
out the monitoring period starting from D18. Within
this follow up period BW improvement in the groups
treated with DCM-250 mg/kg and DCM-200 mg/kg was
not significantly different (p > 0.05), though better incre-
ment was produced by DCM −250 mg/kg (Fig. 3a). On
the other hand, only MOH-250 mg/kg and MOH-
200 mg/kg were able to significantly improve BW com-
pared to the control group (p < 0.05), though MOH-
250 mg/kg was statistically superior (p < 0.01) to MOH-
200 mg/kg in improving BW of mice. By contrast, there
was consistent BW lose in mice treated with MOH-
150 mg/kg and MOH-100 mg/kg (Fig. 3b). Comparative
analysis revealed that significant (p < 0.05) BW improve-
ment was observed in mice treated with MOH-250 mg/
kg (6.1 %), DCM-250 mg/kg (4.7 %), and diminazene
aceturate 28 mg/kg (4.6 %) compared to those treated
Fig. 1 In vivo anti-trypanosomal activity of crude dichloromethane and methanol leaf extracts of D. abyssinica on packed cell volume of mice
infected with T. congolense. Values are Means, N = 5; p < 0.01; acompared to DCM150; bcompared to DCM100; ccompared to MOH150; dcompared
to MOH100; ecompared to DMSO; DCM Dichloromethane extract, MOH Methanol extract, DA Diminazene aceturate, DMSO Dimethylsulfoxide, PCV
Packed cell volume, D Day, D12 Day of treatment initiation
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with MOH-200 mg/kg on days 22, 24 and 26. However,
the difference in BW improvement produced by these
doses were statistically insignificant (p > 0.05).
Effect of extracts on mean survival time
Higher doses of DCM extracts (250 and 200 mg/kg) sig-
nificantly (p < 0.05) prolonged mean survival time of in-
fected mice compared to that conferred by treatments
with DCM-150 mg/kg, DCM-100 mg/kg, and DMSO
which was below 34 days. Similarly, mice treated with
MOH-250 mg/kg and MOH-200 mg/kg survived longer
time than those treated with lower MOH doses (150 and
100 mg/kg) and DMSO. Significantly longer (p < 0.05)
survival time (41.40 ± 0.24 days) was recorded in mice
treated with DCM-250 mg/kg compared to those treated
with MOH-250 mg/kg (40.20 ± 0.49), DCM-200 mg/kg
(39.40 ± 0.24) and MOH-200 mg/kg (38.60 ± 0.51) which
were statistically indifferent (p > 0.05) amongst themselves.
All mice treated with 28 mg/kg diminazene aceturate sur-
vived until the end of the monitoring period of 42 days.
Out of 40 mice treated with both extracts, only three (two
DCM-250 mg/kg and one MOH-250 mg/kg treated) mice
survived up to the end of the monitoring period (Fig. 4).
Discussion
In this study the activity of crude DCM and MOH leaf
extracts of D. abyssinica were studied in terms of in vivo
parameters, including parasitemia, packed cell volume,
rectal temperature, BW and mean survival time of in-
fected mice.
Higher doses (250 and 200 mg/kg) of both extracts
substantially reduced parasitemia level in mice, despite
the failure to completely clear bloodstream form of the
parasite. The result is consistent with other reports [25,
28] that medicinal plants reduce parasitemia. The effect
might be attributed to the presence in them of one or
Fig. 2 Rectal temperature change of T. congolense infected mice treated with crude dichloromethane (a) and methanol (b) leaf extract of D.
abyssinica. Values are Means, N = 5; 1p < 0.05; 2p < 0.01; aagainst 200 mg/kg; bagainst 150 mg/kg; cagainst 100 mg/kg; dagainst DA; DCM-
250150 mg/kg Dichloromethane extract 250 mg/kg, DCM200 Dichloromethane extract 200 mg/kg, DCM150 Dichloromethane extract 150 mg/kg,
DCM100 Dichloromethane extract 100 mg/kg, DA Diminazene aceturate, DMSO Dimethylsulfoxide, D0 Day of parasite inoculation, D12 day of
treatment initiation
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more of secondary metabolites which may exert their ef-
fects through the additive or synergistic action of several
chemical compounds acting at a single or multiple target
sites associated with a physiological process [29, 30].
Even though detailed characterization and isolation of
different compounds that could be responsible for the
observed activity was not carried out, preliminary phyto-
chemical screening indicated the presence of alkaloids,
phenolic compounds, flavonoids, sapponins, and ste-
roids. Several possible mechanisms, therefore, working
separately or in concert may account for the observed
effect [31].
D. abyssinica contains spermidine alkaloids [12], also
confirmed in the present study, that may in part account
for the observed anitrypanosomal activity of this plant
[14]. The aryl moiety in the spermidine molecule inter-
acts with the hydrophobic region of trypanothione re-
ductase so that the spermidine would adopt a non-
extended bound conformation [32], could be responsible
for the observed effect of the alkaloid. Besides, the ex-
tracts may increase oxygen consumption and stimulation
of hydrogen peroxide production in the protozoan cell
[33]. Hence, the parasite might have been exposed to
oxidative stress that couldn’t be dealt with the inhibited
trypanothione pathway. Interestingly, spermidine in part
resembles the chemical structure of pentamidine [14].
Binding to nucleic acids in DNA and RNA, or promo-
tion of cleavage of the parasite’s circular DNA in a
Fig. 3 Percentage Body Weight change of T. congolense infected mice treated with crude dichloromethane (a) and methanol (b) leaf extracts
of D. abyssinica. Values are Means, N = 5; 1p < 0.05; 2p < 0.01; aagainst 200 mg/kg; bagainst 150 mg/kg; cagainst 100 mg/kg; dagainst DA; DCM250
Dichloromethane extract 250 mg/kg; DCM200 Dichloromethane extract 200 mg/kg, DCM150 Dichloromethane extract 150 mg/kg, DCM100
Dichloromethane extract 100 mg/kg, DA Diminazene aceturate, DMSO Dimethylsulfoxide, D0 Day of parasite inoculation, D12 Day of
treatment initiation
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manner similar to that of topoisomerase II inhibitors
might have also been responsible [34].
But this may not rule out the actions of the other sec-
ondary metabolites. Flavonoids targeting the replicating
form of trypanosomes which are totally dependent on
glycolysis for energy production [35] might have been
responsible mechanisms. It may also be proposed that
phenolic compounds, though only found in DCM extract,
might have killed the parasite through specific inhib-
ition of the glycerol-3-phosphate-dependent mitochon-
drial oxygen consumption or formation of reactive
oxygen species acting as a pro-oxidant [36]. Moreover,
steroids should not be neglected in this regard since ste-
rols, such as vernoguinosterol and vernoguinoside, have
been reported to have anti-trypanosomal activities [37].
On the other hand, although the anti-trypanosomal activ-
ity of saponins is controversial, saponins with detergent
properties can dissolve in biomembranes and disturb their
fluidity and the function of membrane proteins of para-
sites [38].
At similar in vivo doses DCM extract was superior to
its MOH counterpart, which is consistent with previous
report [14]. This may be credited to the presence of
phenolic compounds in the DCM, but not in the MOH,
extract as these compounds were shown to exhibit anti-
trypanosomal activity [39]. Other report has shown simi-
lar observation that superior activity was obtained from
the DCM plant extracts [28].
The observation that parasitemia was relatively ele-
vated and that trypanosomes were persistently present
in blood of extract treated animals after withdrawal of
treatment (day 12, 14) may suggest recovery of the para-
sites from the suppressive effect of the extracts. This
resurgence in mean parasitemia may be due to the wan-
ing effect of the treatment [28] or the release of trypano-
somes from the tissues which can occur when treatment
is delayed or the dose rate is inadequate [22]. Despite
the temporary clearance of blood stream forms of try-
panosomes, relapse occurred in all mice treated with
diminazene aceturate at day 12 post-treatment initiation.
This observation is not surprising as resistance to dimin-
azene aceturate has been widespread in South West
Ethiopia [40].
Consistent with reduction in parasitemia, it is apparent
from results of the present study that administration of
both extracts at higher doses (250 and 200 mg/kg) led to
remarkable improvement of anemia, evident from the
significant difference in the levels of the PCV of the ex-
tract treated animals and those treated with DMSO. The
result is consistent with previous works [23, 28]. The in-
crease in PCV after treatment may, therefore, be due to
mechanisms associated with reduction in trypanolytic
crisis which enhances red blood cells damage and de-
struction leading to anemia [41]. This, in turn, may be
mediated by extracts ability to eliminate parasites from
the blood, probably by reaching the site of action or
rapid metabolization [42], or neutralization of the toxic
metabolites produced by trypanosomes [43]. Certain
components of the plant might have helped stabilize the
membrane of erythrocytes; specifically, the anti-oxidant
or free radical scavenging properties of phenolic com-
pounds and flavonoids [44], may play vital roles in this
regard.
Animals infected with trypanosomes characteristically
exhibit fever shown in the present study by the occur-
rence of febrile peaks which reflected the response to
Fig. 4 In vivo anti-trypanosomal activity of dichloromethane and methanol crude leaf extracts of D. abyssinica on mean survival time of mice
infected with T. congolense. Values are Means, N = 5; 1p < 0.05; 2p < 0.01; acompared to DCM200 and MOH200; bcompared to DCM150 and
MOH150; ccompared to DCM100 and MOH 100; dcompared to DMSO; DA Diminazene aceturate, DCM Dichloromethane extract, MOH Methanol
extract, DMSO dimethylsulfoxide
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successive waves of parasitemia that the high body
temperature itself is detrimental to the trypanosomes
[45]. However, following treatment with high doses (250
and 200 mg/kg) of both extracts pyrexia was reduced
with attendant rise in packed cell values. The body
temperature set point in the hypothalamus, which was
changed under the influence of pyrogenic stimuli re-
leased during infection [46], might have, then, been kept
in check.
Further deduction of the anti-trypanosomal activity of
the plant can be made from the weight gain observed in
mice treated with the higher (250, 200 mg/kg) doses of
extracts. In the present study, infected mice manifested
weight loss and similar findings have been reported in T.
congolense infected West African dwarf goats [47] and in
mice infected with T. congolense [28]. The weight gain
might be linked to the treatment-induced reduction of
parasitemia, which otherwise would lead to depressed
appetite and food intake during fever peaks. Fever re-
duction might, therefore, have decreased synthesis of
protein that would occur at the expense of muscle pro-
tein catabolism and loss in body weight [48]. The in-
creased supply of oxygen and nutrients because of the
improved PCV level may also be an important factor in
the weight gain.
Compared to DMSO treatment, administration of
higher doses (250 and 200 mg/kg) of both extracts con-
ferred prolongation of lives of mice. The result agrees
with other reports [49, 28] that medicinal plants prolong
survival of trypanosome infected mice. This could be re-
lated to effects of the active compound found in D. abys-
sinica on red blood cells and/or antioxidant activity. The
amelioration of anemia, which is primarily responsible
for the death of infected animals [49], shown by the abil-
ity of these extracts to improve PCV may have then res-
cued the lives of mice. Additionally, the improved
survival of trypanosome infected mice could be due to
the effects of D. abyssinica leaf extracts on pathogenesis
of the disease. Indeed polyphenols in tea have been
shown to attenuate cytokine induced [50] and also nitric
oxide inflammation [51], both of which initiate the
pathological effects of trypanosomiasis [49].
Conclusion
In the present study, administration of higher curative
doses (250 and 200 mg/kg) of both extracts considerably
displayed in vivo activity as evidenced by reduction in
parasitemia level, and rectal temperature and enhanced
packed cell volume, body weight, and survival time.
Therefore, it could be concluded that crude dichloro-
methane and methanol leaf extracts of D. abyssinica dis-
played anti-trypanosomal activity that may serve as lead
for the development of effective alternative antitrypano-
somal drugs. However, bioactivity-driven isolation of D.
abyssinica components and further antitrypanosomal ac-
tivity studies are necessary to evaluate the pharmaco-
logical importance of the plant.
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